Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0479 Transporter Info
Gene Name	SLC8A3
Transporter Name	Sodium/calcium exchanger 3
Gene ID	6547
UniProt ID	P57103

Post-Translational Modification of This DT
Overview of SLC8A3 Modification Sites with Functional and Structural Information
Sequence	M A W L R L Q P L T S A F L H F G L V T F V L F L N G L R A E A G G S G D V P S T G Q N N E S C S G S S D C K E G V I L P I W Y P E N P S L G D K I A R V I V Y F V A L I Y M F L G V S I I A D R F M A S I E V I T S Q E R E V T I K K P N G E T S T T T I R V W N E T V S N L T L M A L G S S A P E I L L S L I E V C G H G F I A G D L G P S T I V G S A A F N M F I I I G I C V Y V I P D G E T R K I K H L R V F F I T A A W S I F A Y I W L Y M I L A V F S P G V V Q V W E G L L T L F F F P V C V L L A W V A D K R L L F Y K Y M H K K Y R T D K H R G I I I E T E G D H P K G I E M D G K M M N S H F L D G N L V P L E G K E V D E S R R E M I R I L K D L K Q K H P E K D L D Q L V E M A N Y Y A L S H Q Q K S R A F Y R I Q A T R M M T G A G N I L K K H A A E Q A K K A S S M S E V H T D E P E D F I S K V F F D P C S Y Q C L E N C G A V L L T V V R K G G D M S K T M Y V D Y K T E D G S A N A G A D Y E F T E G T V V L K P G E T Q K E F S V G I I D D D I F E E D E H F F V R L S N V R I E E E Q P E E G M P P A I F N S L P L P R A V L A S P C V A T V T I L D D D H A G I F T F E C D T I H V S E S I G V M E V K V L R T S G A R G T V I V P F R T V E G T A K G G G E D F E D T Y G E L E F K N D E T V K T I R V K I V D E E E Y E R Q E N F F I A L G E P K W M E R G I S A L L L S P D V T D R K L T M E E E E A K R I A E M G K P V L G E H P K L E V I I E E S Y E F K T T V D K L I K K T N L A L V V G T H S W R D Q F M E A I T V S A A G D E D E D E S G E E R L P S C F D Y V M H F L T V F W K V L F A C V P P T E Y C H G W A C F A V S I L I I G M L T A I I G D L A S H F G C T I G L K D S V T A V V F V A F G T S V P D T F A S K A A A L Q D V Y A D A S I G N V T G S N A V N V F L G I G L A W S V A A I Y W A L Q G Q E F H V S A G T L A F S V T L F T I F A F V C I S V L L Y R R R P H L G G E L G G P R G C K L A T T W L F V S L W L L Y I L F A T L E A Y C Y I K G F
PTM type	X-N-glycosylation X-O-glycosylation X-Oxidation X-Phosphorylation X-SUMOylation X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	45
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC8A3 Asparagine 45 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A3			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	823
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC8A3 Asparagine 823 has the potential to affect its expression or activity.
O-glycosylation
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A3			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	568
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC8A3 Threonine 568 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A3			[3]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC8A3 Cystine 54 has the potential to affect its expression or activity.
Phosphorylation
Serine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A3			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	381
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Serine 381 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A3			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Serine 382 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC8A3			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	384
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Serine 384 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A3			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	388
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Threonine 388 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A3			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	597
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Threonine 597 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC8A3			[7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	638
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Threonine 638 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC8A3			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	643
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Threonine 643 has the potential to affect its expression or activity.
Tyrosine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC8A3			[10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	341
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Tyrosine 341 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC8A3			[10]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	342
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Tyrosine 342 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC8A3			[6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	608
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC8A3 Tyrosine 608 has the potential to affect its expression or activity.
SUMOylation
Lysine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Accelerating SLC8A3 degradation			[11]
Role of PTM	Degradation via Proteosome
Modified Residue	Lysine	Modified Location	590
Experimental Method	Co-Immunoprecipitation
Detailed Description	SUMOylation at SLC8A3 Lysine 590 have been reported to accelerate its degradation, thereby affecting its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: NAC3_HUMAN)
2	A triarylphosphine-trimethylpiperidine reagent for the one-step derivatization and enrichment of protein post-translational modifications and identification by mass spectrometry. Chem Commun (Camb). 2018 Dec 6;54(98):13790-13793.
3	Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
4	Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
5	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
6	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
7	Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability. Mol Cell Proteomics. 2017 Sep;16(9):1694-1704.
8	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
9	Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell. 2009 Aug 7;5(2):204-13.
10	Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
11	Sumoylation of LYS590 of NCX3 f-Loop by SUMO1 Participates in Brain Neuroprotection Induced by Ischemic Preconditioning. Stroke. 2016 Apr;47(4):1085-93.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence